Key Financial Data Of Group

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7537523

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
2023-07-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
2022-07-01 to
2022-09-30
Key financial data of group
Business results of group
Net sales
3,618,388,000 JPY
8,660,379,000 JPY
4,019,650,000 JPY
Ordinary profit (loss)
-319,840,000 JPY
242,574,000 JPY
-27,945,000 JPY
Net assets
12,032,325,000 JPY
11,906,669,000 JPY
11,579,077,000 JPY
Total assets
15,811,544,000 JPY
15,711,553,000 JPY
14,737,616,000 JPY
Basic earnings (loss) per share
-6.42
-9.32
3.98
-0.62
-0.48
Diluted earnings per share
Equity-to-asset ratio
0.7609 xbrli:pure
0.7578 xbrli:pure
0.7857 xbrli:pure
Net cash provided by (used in) operating activities
108,673,000 JPY
631,920,000 JPY
254,291,000 JPY
Net cash provided by (used in) investing activities
78,066,000 JPY
17,131,000 JPY
149,649,000 JPY
Net cash provided by (used in) financing activities
-104,307,000 JPY
-1,615,000 JPY
-1,031,000 JPY
Cash and cash equivalents
3,961,757,000 JPY
3,879,325,000 JPY
3,634,798,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.